CN Stock MarketDetailed Quotes

Huadong Medicine (000963)

Watchlist
  • 34.54
  • -0.64-1.82%
Trading Apr 27 09:39 CST
60.57BMarket Cap17.30P/E (TTM)

Huadong Medicine (000963) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
4.17%11.18B
4.07%43.61B
3.77%32.66B
3.39%21.67B
3.12%10.74B
3.16%41.91B
3.56%31.48B
2.84%20.97B
2.93%10.41B
7.71%40.62B
Operating revenue
4.17%11.18B
4.07%43.61B
3.77%32.66B
3.39%21.67B
3.12%10.74B
3.16%41.91B
3.56%31.48B
2.84%20.97B
2.93%10.41B
7.71%40.62B
Other operating revenue
----
1.74%404.2M
----
16.18%166.11M
----
9.62%397.3M
----
4.01%142.98M
----
60.37%362.43M
Total operating cost
3.88%9.99B
5.06%39.39B
3.54%29.29B
2.87%19.42B
3.09%9.62B
1.11%37.49B
2.72%28.29B
2.35%18.88B
2.42%9.33B
7.27%37.08B
Operating cost
2.51%7.39B
5.40%29.5B
2.28%21.72B
1.54%14.33B
1.84%7.21B
1.92%27.99B
2.51%21.23B
1.38%14.11B
4.21%7.08B
6.93%27.46B
Operating tax surcharges
18.35%67.77M
-1.63%246.54M
5.61%172.98M
3.22%114.59M
1.65%57.27M
7.76%250.64M
5.63%163.79M
4.05%111.01M
5.99%56.33M
11.65%232.59M
Operating expense
23.79%1.82B
1.85%6.53B
1.36%4.79B
-1.40%3.23B
-6.58%1.47B
-3.56%6.41B
1.40%4.73B
6.19%3.27B
-4.16%1.57B
4.90%6.65B
Administration expense
4.50%371.4M
-3.81%1.34B
-7.55%1.09B
1.49%725.3M
6.03%355.4M
-1.61%1.4B
6.62%1.18B
-0.95%714.63M
1.54%335.17M
13.73%1.42B
Financial expense
-132.33%-4.73M
-15.68%18.77M
-70.20%11.33M
-4.27%22.42M
93.49%14.62M
-56.51%22.26M
-40.63%38.02M
-58.06%23.42M
-74.08%7.56M
-34.59%51.19M
-Interest expense (Financial expense)
-26.03%19.18M
-6.39%94.73M
-0.05%86.55M
1.07%56.15M
12.47%25.92M
-15.32%101.2M
2.69%86.59M
0.27%55.55M
-33.12%23.05M
-6.38%119.51M
-Interest Income (Financial expense)
27.53%-20.16M
20.65%-82.52M
9.60%-72.33M
14.17%-45.61M
-13.94%-27.81M
-10.58%-104M
-29.72%-80.01M
-60.93%-53.14M
-95.41%-24.41M
9.00%-94.05M
Research and development
-32.02%350.37M
22.97%1.75B
58.92%1.51B
55.44%999.67M
82.99%515.38M
12.19%1.43B
12.83%948.66M
15.17%643.11M
6.08%281.64M
25.08%1.27B
Credit Impairment Loss
----
-22.05%-136.91M
-44.91%-83.96M
-44.91%-83.96M
----
-335.42%-112.18M
-37.88%-57.94M
-59.03%-57.94M
----
62.49%-25.76M
Asset Impairment Loss
----
-114.35%-87.9M
----
----
----
-528.94%-41.01M
----
----
----
-70.60%-6.52M
Other net revenue
-42.62%9.45M
-31.02%-115.24M
-190.36%-23.95M
-83.68%-13.14M
323.99%16.48M
1.11%-87.95M
118.10%26.51M
95.01%-7.15M
85.10%-7.36M
-5.18%-88.94M
Fair value change income
----
----
----
----
----
----
----
----
---25.36K
-148.32%-13.76M
Invest income
47.66%-22.31M
-6.70%-137.84M
-37.66%-119.37M
-40.59%-67.27M
9.62%-42.62M
41.20%-129.19M
48.64%-86.71M
65.05%-47.85M
23.63%-47.16M
-55.21%-219.71M
-Including: Investment income associates
73.42%-7.51M
-10.91%-75.92M
-37.92%-75.25M
-40.03%-35.37M
24.68%-28.25M
63.66%-68.45M
62.45%-54.56M
79.03%-25.26M
28.99%-37.5M
-62.94%-188.39M
Asset deal income
103.68%534.95K
141.43%2.26M
-16.53%1.82M
-225.85%-6.2M
-1,055.84%-14.54M
-226.47%-5.46M
-39.32%2.18M
39.99%4.93M
169.15%1.52M
-47.69%4.32M
Other revenue
-57.59%31.23M
22.64%245.15M
5.07%177.56M
53.98%144.29M
92.22%73.64M
15.88%199.89M
139.29%168.98M
169.17%93.71M
162.72%38.31M
85.91%172.49M
Operating profit
5.99%1.2B
-5.01%4.11B
4.21%3.35B
7.80%2.24B
5.61%1.13B
25.25%4.32B
18.71%3.22B
15.72%2.08B
12.39%1.07B
12.79%3.45B
Add:Non operating Income
63.43%1.26M
-61.13%34.21M
-24.23%5.64M
-20.38%4.16M
-40.64%769.1K
74.11%88.01M
110.42%7.44M
75.66%5.22M
-6.74%1.3M
564.38%50.55M
Less:Non operating expense
-67.60%9.1M
12.95%125.64M
5.28%93.61M
43.89%54.37M
439.64%28.08M
196.70%111.23M
270.46%88.91M
131.83%37.78M
-13.99%5.2M
-1.18%37.49M
Total profit
7.90%1.19B
-6.63%4.02B
4.11%3.26B
7.06%2.19B
3.44%1.1B
24.11%4.3B
16.58%3.13B
14.76%2.05B
12.53%1.07B
14.35%3.47B
Less:Income tax cost
2.13%195.03M
-24.99%605.62M
-8.84%520.76M
8.19%389.83M
-8.16%190.97M
30.30%807.33M
15.51%571.28M
4.36%360.34M
9.82%207.94M
24.29%619.59M
Net profit
9.10%997.16M
-2.39%3.41B
6.99%2.74B
6.82%1.8B
6.25%913.98M
22.76%3.49B
16.82%2.56B
17.25%1.69B
13.20%860.25M
12.39%2.85B
Net profit from continuing operation
9.10%997.16M
-2.39%3.41B
6.99%2.74B
6.82%1.8B
6.25%913.98M
22.76%3.49B
16.82%2.56B
17.25%1.69B
13.20%860.25M
12.39%2.85B
Less:Minority Profit
-594.18%-5.03M
80.53%-3.49M
-2,282.43%-6.06M
-47.30%-11.5M
66.56%-724.3K
-337.77%-17.92M
-93.83%277.57K
-229.42%-7.81M
-146.68%-2.17M
-77.44%7.54M
Net profit of parent company owners
9.56%1B
-2.78%3.41B
7.24%2.75B
7.01%1.81B
6.06%914.71M
23.72%3.51B
17.05%2.56B
18.29%1.7B
14.18%862.41M
13.59%2.84B
Earning per share
Basic earning per share
9.40%0.5715
-2.80%1.9484
7.09%1.5682
6.39%1.0293
5.98%0.5224
23.60%2.0046
17.06%1.4644
18.07%0.9675
14.20%0.4929
13.55%1.6219
Diluted earning per share
9.63%0.5715
-2.84%1.9465
7.02%1.5666
6.81%1.0346
5.78%0.5213
23.61%2.0034
17.08%1.4639
18.27%0.9686
14.21%0.4928
13.47%1.6207
Other composite income
-198.25%-80.61M
649.58%56.37M
371.61%83.36M
477.95%23.76M
102.13%82.04M
-120.31%-10.26M
554.51%17.68M
29.29%-6.29M
229.47%40.59M
223.84%50.51M
Other composite income of parent company owners
-198.25%-80.61M
649.58%56.37M
371.61%83.36M
477.95%23.76M
102.13%82.04M
-120.31%-10.26M
554.51%17.68M
29.29%-6.29M
229.47%40.59M
223.84%50.51M
Total composite income
-7.98%916.55M
-0.48%3.47B
9.49%2.83B
8.63%1.83B
10.57%996.03M
20.26%3.48B
17.84%2.58B
17.54%1.68B
23.64%900.84M
16.26%2.9B
Total composite income of parent company owners
-7.54%921.58M
-0.89%3.47B
9.74%2.83B
8.81%1.84B
10.38%996.75M
21.20%3.5B
18.07%2.58B
18.58%1.69B
24.74%903M
17.53%2.89B
Total composite income of minority owners
-594.18%-5.03M
80.53%-3.49M
-2,282.43%-6.06M
-47.30%-11.5M
66.56%-724.3K
-337.77%-17.92M
-93.83%277.57K
-229.42%-7.81M
-146.68%-2.17M
-77.44%7.54M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue 4.17%11.18B4.07%43.61B3.77%32.66B3.39%21.67B3.12%10.74B3.16%41.91B3.56%31.48B2.84%20.97B2.93%10.41B7.71%40.62B
Operating revenue 4.17%11.18B4.07%43.61B3.77%32.66B3.39%21.67B3.12%10.74B3.16%41.91B3.56%31.48B2.84%20.97B2.93%10.41B7.71%40.62B
Other operating revenue ----1.74%404.2M----16.18%166.11M----9.62%397.3M----4.01%142.98M----60.37%362.43M
Total operating cost 3.88%9.99B5.06%39.39B3.54%29.29B2.87%19.42B3.09%9.62B1.11%37.49B2.72%28.29B2.35%18.88B2.42%9.33B7.27%37.08B
Operating cost 2.51%7.39B5.40%29.5B2.28%21.72B1.54%14.33B1.84%7.21B1.92%27.99B2.51%21.23B1.38%14.11B4.21%7.08B6.93%27.46B
Operating tax surcharges 18.35%67.77M-1.63%246.54M5.61%172.98M3.22%114.59M1.65%57.27M7.76%250.64M5.63%163.79M4.05%111.01M5.99%56.33M11.65%232.59M
Operating expense 23.79%1.82B1.85%6.53B1.36%4.79B-1.40%3.23B-6.58%1.47B-3.56%6.41B1.40%4.73B6.19%3.27B-4.16%1.57B4.90%6.65B
Administration expense 4.50%371.4M-3.81%1.34B-7.55%1.09B1.49%725.3M6.03%355.4M-1.61%1.4B6.62%1.18B-0.95%714.63M1.54%335.17M13.73%1.42B
Financial expense -132.33%-4.73M-15.68%18.77M-70.20%11.33M-4.27%22.42M93.49%14.62M-56.51%22.26M-40.63%38.02M-58.06%23.42M-74.08%7.56M-34.59%51.19M
-Interest expense (Financial expense) -26.03%19.18M-6.39%94.73M-0.05%86.55M1.07%56.15M12.47%25.92M-15.32%101.2M2.69%86.59M0.27%55.55M-33.12%23.05M-6.38%119.51M
-Interest Income (Financial expense) 27.53%-20.16M20.65%-82.52M9.60%-72.33M14.17%-45.61M-13.94%-27.81M-10.58%-104M-29.72%-80.01M-60.93%-53.14M-95.41%-24.41M9.00%-94.05M
Research and development -32.02%350.37M22.97%1.75B58.92%1.51B55.44%999.67M82.99%515.38M12.19%1.43B12.83%948.66M15.17%643.11M6.08%281.64M25.08%1.27B
Credit Impairment Loss -----22.05%-136.91M-44.91%-83.96M-44.91%-83.96M-----335.42%-112.18M-37.88%-57.94M-59.03%-57.94M----62.49%-25.76M
Asset Impairment Loss -----114.35%-87.9M-------------528.94%-41.01M-------------70.60%-6.52M
Other net revenue -42.62%9.45M-31.02%-115.24M-190.36%-23.95M-83.68%-13.14M323.99%16.48M1.11%-87.95M118.10%26.51M95.01%-7.15M85.10%-7.36M-5.18%-88.94M
Fair value change income -----------------------------------25.36K-148.32%-13.76M
Invest income 47.66%-22.31M-6.70%-137.84M-37.66%-119.37M-40.59%-67.27M9.62%-42.62M41.20%-129.19M48.64%-86.71M65.05%-47.85M23.63%-47.16M-55.21%-219.71M
-Including: Investment income associates 73.42%-7.51M-10.91%-75.92M-37.92%-75.25M-40.03%-35.37M24.68%-28.25M63.66%-68.45M62.45%-54.56M79.03%-25.26M28.99%-37.5M-62.94%-188.39M
Asset deal income 103.68%534.95K141.43%2.26M-16.53%1.82M-225.85%-6.2M-1,055.84%-14.54M-226.47%-5.46M-39.32%2.18M39.99%4.93M169.15%1.52M-47.69%4.32M
Other revenue -57.59%31.23M22.64%245.15M5.07%177.56M53.98%144.29M92.22%73.64M15.88%199.89M139.29%168.98M169.17%93.71M162.72%38.31M85.91%172.49M
Operating profit 5.99%1.2B-5.01%4.11B4.21%3.35B7.80%2.24B5.61%1.13B25.25%4.32B18.71%3.22B15.72%2.08B12.39%1.07B12.79%3.45B
Add:Non operating Income 63.43%1.26M-61.13%34.21M-24.23%5.64M-20.38%4.16M-40.64%769.1K74.11%88.01M110.42%7.44M75.66%5.22M-6.74%1.3M564.38%50.55M
Less:Non operating expense -67.60%9.1M12.95%125.64M5.28%93.61M43.89%54.37M439.64%28.08M196.70%111.23M270.46%88.91M131.83%37.78M-13.99%5.2M-1.18%37.49M
Total profit 7.90%1.19B-6.63%4.02B4.11%3.26B7.06%2.19B3.44%1.1B24.11%4.3B16.58%3.13B14.76%2.05B12.53%1.07B14.35%3.47B
Less:Income tax cost 2.13%195.03M-24.99%605.62M-8.84%520.76M8.19%389.83M-8.16%190.97M30.30%807.33M15.51%571.28M4.36%360.34M9.82%207.94M24.29%619.59M
Net profit 9.10%997.16M-2.39%3.41B6.99%2.74B6.82%1.8B6.25%913.98M22.76%3.49B16.82%2.56B17.25%1.69B13.20%860.25M12.39%2.85B
Net profit from continuing operation 9.10%997.16M-2.39%3.41B6.99%2.74B6.82%1.8B6.25%913.98M22.76%3.49B16.82%2.56B17.25%1.69B13.20%860.25M12.39%2.85B
Less:Minority Profit -594.18%-5.03M80.53%-3.49M-2,282.43%-6.06M-47.30%-11.5M66.56%-724.3K-337.77%-17.92M-93.83%277.57K-229.42%-7.81M-146.68%-2.17M-77.44%7.54M
Net profit of parent company owners 9.56%1B-2.78%3.41B7.24%2.75B7.01%1.81B6.06%914.71M23.72%3.51B17.05%2.56B18.29%1.7B14.18%862.41M13.59%2.84B
Earning per share
Basic earning per share 9.40%0.5715-2.80%1.94847.09%1.56826.39%1.02935.98%0.522423.60%2.004617.06%1.464418.07%0.967514.20%0.492913.55%1.6219
Diluted earning per share 9.63%0.5715-2.84%1.94657.02%1.56666.81%1.03465.78%0.521323.61%2.003417.08%1.463918.27%0.968614.21%0.492813.47%1.6207
Other composite income -198.25%-80.61M649.58%56.37M371.61%83.36M477.95%23.76M102.13%82.04M-120.31%-10.26M554.51%17.68M29.29%-6.29M229.47%40.59M223.84%50.51M
Other composite income of parent company owners -198.25%-80.61M649.58%56.37M371.61%83.36M477.95%23.76M102.13%82.04M-120.31%-10.26M554.51%17.68M29.29%-6.29M229.47%40.59M223.84%50.51M
Total composite income -7.98%916.55M-0.48%3.47B9.49%2.83B8.63%1.83B10.57%996.03M20.26%3.48B17.84%2.58B17.54%1.68B23.64%900.84M16.26%2.9B
Total composite income of parent company owners -7.54%921.58M-0.89%3.47B9.74%2.83B8.81%1.84B10.38%996.75M21.20%3.5B18.07%2.58B18.58%1.69B24.74%903M17.53%2.89B
Total composite income of minority owners -594.18%-5.03M80.53%-3.49M-2,282.43%-6.06M-47.30%-11.5M66.56%-724.3K-337.77%-17.92M-93.83%277.57K-229.42%-7.81M-146.68%-2.17M-77.44%7.54M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More